FlowPhysix Partners with 3comma to Enhance Global Thrombectomy Device Distribution
FlowPhysix and 3comma Forge Strategic International Alliance
FlowPhysix™ Inc., previously recognized as Expanse ICE, has officially announced a strategic partnership with 3comma Medical GmbH for the commercial distribution of its innovative FLOWRUNNER™ Aspiration System. This collaboration marks a significant step in expanding access to enhanced thrombectomy solutions for healthcare professionals around the globe.
About 3comma's Expertise in Medical Device Commercialization
3comma serves as a leading international commercialization agency, specializing in the growth of revenue streams for emerging medical device companies. With a wealth of experience, 3comma is poised to assist FlowPhysix in establishing new standards in thrombectomy technology worldwide, thereby allowing FlowPhysix to concentrate its efforts on the commercialization within the United States.
Estimating the Impact of the Partnership
The collaboration is predicted to have an immediate impact on the global thrombectomy market. Marc Paris, Managing Partner at 3comma and former Vice President of International at Penumbra, Inc., stated, "We can rapidly activate our established infrastructure to catalyze the FLOURUNNER System's adoption. We believe in FlowPhysix as the next critical player in this vibrant market."
The FLOWRUNNER™ Aspiration System: A New Era of Thrombectomy Technology
The FLOWRUNNER System addresses the vacuum decay challenges common in traditional aspiration catheters. By utilizing FlowPhysix’s proprietary technology, the system enables an efficient method for clot removal. The aspiration catheter works by navigating through a sheath and exiting through a distal valve, applying sustained and effective aspiration force directly to the thrombus.
Understanding the Mechanism Behind the Device’s Success
This technology continually cycles between the extension and retraction of the aspiration catheter, effectively shearing and evacuating segments of thrombus with the aid of an integrated saline flush. The FLOWRUNNER has demonstrated success in removing diverse and considerable thrombi, leading to the restoration of proper blood flow.
A Vision for the Future of Thrombectomy Care
CEO Jeff Hopkins expressed optimism regarding this collaboration: "Our technology has the potential to redefine thrombectomy standards. This partnership expands our capacity to deliver our innovative solutions to patients across the globe. We are confident that 3comma’s extensive expertise will spearhead our international commercial success and enhance shareholder value," he added.
For More Information
To explore more about FlowPhysix and its revolutionary thrombectomy system, interested parties can visit their official website for details on the FLOWRUNNER and its capabilities.
Frequently Asked Questions
What is the FLOWRUNNER™ Aspiration System?
The FLOWRUNNER™ Aspiration System is an innovative medical device designed to improve the thrombectomy process by efficiently removing clots and restoring blood flow.
How does the technology work?
It uses a specialized catheter that applies consistent aspiration force, cyclically extending and retracting to effectively shear and evacuate thrombi.
Who is 3comma, and what role will they play?
3comma is an international commercialization agency that will help FlowPhysix distribute the FLOWRUNNER system globally, leveraging their expertise to enhance market adoption.
How will this partnership impact healthcare providers?
The partnership aims to provide healthcare professionals outside of the United States with improved access to advanced thrombectomy technology, enhancing patient outcomes.
What is FlowPhysix's vision moving forward?
FlowPhysix envisions redefining the current standards of care in thrombectomy while expanding their reach and increasing shareholder value through strategic partnerships.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.